NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDAbiraterone 250mg
(Tablets) 		Malignant disease and immunosuppression, Anti-androgens, 08.03.04.02
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Abiraterone  Abiraterone Acetate Malignant Disease, Antineoplastic Drugs, Anti-Androgens
Hormone Responsive Malignancy
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
MHRA Drug Safety Update (Dec 2017): Radium-223 dichloride (Xofigo▼): do not use in combination with abiraterone and prednisone/prednisolone, following clinical trial signal of increased risk of death and fractures
NICE TA1032: Niraparib with abiraterone acetate and prednisone for untreated hormone-relapsed metastatic prostate cancer (TERMINATED APPRAISAL)
NICE TA1110: Abiraterone (originator and generics) for treating newly diagnosed high-risk hormone‑sensitive metastatic prostate cancer
NICE TA259: Abiraterone for castration resistant prostate cancer
NICE TA387: Abiraterone for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicated
NICE TA951: Olaparib with abiraterone for untreated hormone-relapsed metastatic prostate cancer